No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab
-
Camptothecin / administration & dosage
-
Camptothecin / adverse effects*
-
Camptothecin / analogs & derivatives*
-
Humans
-
Incidence
-
Irinotecan
-
Risk Factors
-
Stomach Neoplasms / complications
-
Stomach Neoplasms / drug therapy*
-
Thromboembolism / chemically induced*
-
Thromboembolism / epidemiology*
-
Thrombophilia / complications*
-
Thrombophilia / etiology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Irinotecan
-
Camptothecin